The particular microenvironment of the skeletal muscle can be the site of complex immune reactions. Toll-like receptors (TLRs) mediate inflammatory stimuli from pathogens and endogenous danger signals and link the innate and adaptive immune system. We investigated innate immune responses in human muscle. Analyzing TLR1-9 mRNA in cultured myoblasts and rhabdomyosarcoma cells, we found constitutive expression of TLR3. The TLR3 ligand Poly (I:C), a synthetic analog of dsRNA, and IFN-γ increased TLR3 levels. TLR3 was mainly localized intracellularly and regulated at the protein level. Poly (I:C) challenge 1) activated nuclear factor-κB (NF-κB), 2) increased IL-8 release, and 3) up-regulated NKG2D ligands and NK-cell-mediated lysis of muscle cells. We examined muscle biopsy specimens of 6 HIV patients with inclusion body myositis/polymyositis (IBM/PM), 7 cases of sporadic IBM and 9 nonmyopathic controls for TLR3 expression. TLR3 mRNA levels were elevated in biopsy specimens from patients with IBM and HIV-myopathies. Muscle fibers in inflammatory myopathies expressed TLR3 in close proximity of infiltrating mononuclear cells. Taken together, our study suggests an important role of TLR3 in the immunobiology of muscle, and has substantial implications for the understanding of the pathogenesis of inflammatory myopathies or therapeutic interventions like vaccinations or gene transfer. mmunological mechanisms are crucially involved in the pathogenesis of autoimmune, dysimmune, and inflammatory muscle diseases, including the idiopathic inflammatory myopathies (polymyositis (PM), dermatomyositis syndromes, inclusion body myositis (IBM)), myasthenia gravis, and infectious myopathies. Further, immunological reactions can develop in response to degenerative changes in some of the hereditary myopathies, most importantly, the muscular dystrophies. Muscle inflammation may also occur as a local or generalized response to toxic agents as, for example, in macrophagic myofascitis (1).
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Muscle is not just a passive target of immune reactions. On the contrary, muscle cells or myoblasts can express various cytokines, chemokines, adhesion molecules, and costimulatory molecules upon immunological challenge. This enables them to actively participate in immune reactions, for example, as antigen-presenting cells (1) (2) (3) .
The family of TLR proteins mediates signals induced by many pathogen-associated molecular patterns or endogenous damage signals generated at sites of inflammation, and induces antimicrobial immune responses (4) . In humans, 10 members of the TLR family (TLR1-10) have been described so far (reviewed in 5, 6) . Some TLRs act as central integrators of a wide variety of signals, responding to diverse agonists with an apparently common output, while other members of the family show (to date) considerable specificity with regard to stimuli attributed to them (reviewed by Takeda and colleagues (5) and Ulevitch (6) ). Accumulating data demonstrate that TLR are not only major players in defense against pathogens by means of the innate immune system. Moreover, TLR are critical proteins linking innate and adaptive immunity (7) .
TLR3 mediates cellular recognition of dsRNA, produced by many viruses during their replicative cycle (8) , and of cellular mRNA (9) . Exogenously added synthetic dsRNA (Poly (I:C)), or type I IFN up-regulate TLR3 gene expression in macrophages, dendritic cells (DC), and epithelial cells. TLR3, localized in intracellular vesicles, transduces signals to activate NF-κB and the IFN-β promoter (10) . Upon Poly (I:C) stimulation, human myeloid DC produce IFN-α/-β and IL-12-p70 and up-regulate costimulatory molecules such as CD80 and CD86 via TLR3 (11) . It has been shown that pathways linked to TLR3 and TLR9 contribute to innate responses to systemic viral infections. Although neither pathway alone has a dominant role, mutations affecting both result in markedly decreased antiviral responses against a cytomegalovirus infection in mice (12) . Although TLR3 is expressed by DC (13, 11) or NK cells (14) , it is undetectable on monocytes, polymorphonuclear leukocytes, T, or B cells (13) . TLR3 expression is induced during differentiation from monocytes to macrophages with GM-CSF or to immature DC with GM-CSF and IL-4 (11) . The expression of TLR is by no means limited to lymphoid tissues. For example, expression of TLR3 mRNA has been detected in a variety of nonlymphoid tissues such as placenta, pancreas, lung, liver, heart, brain, and human astrocytes (15, 16) , intestinal epithelial cells (17) or human umbilical vein endothelial cells (18), thereby providing evidence for the inherent ability of nonlymphoid tissues to modulate antiviral or antimicrobial immune responses.
Our study aimed at elucidating the expression and the function of TLR in skeletal muscle in vitro and in vivo. We found that muscle cells constitutively express TLR3 mRNA and protein, both up-regulated by Poly (I:C) and IFN-γ. Ligation of TLR3 induces NF-κB activation, IL-8 secretion, and up-regulation of NKG2D-ligands and NK-cell mediated lysis in human myoblasts or TE671 rhabdomyosarcoma cells. Furthermore, TLR3 mRNA and protein is highly expressed in inflammatory and HIV myopathies, thus indicating the importance of this pathway in modulating viral or inflammatory myopathies in vivo.
MATERIAL AND METHODS

Cells and reagents
The TE671 rhabdomyosarcoma cell line was maintained in RPMI 1640 (BioWhittaker Europe, Verviers, Belgium) supplemented with 10% fetal calf serum (PAA Laboratories, Pasching, Austria) and penicillin (100 IU/ml)/streptomycin 100 µg/ml; Life Technologies, Paisley, UK). Myoblasts were isolated from muscle biopsy specimens of nonmyopathic patients, purified by magnetic bead separation and cultured as described by Wiendl and colleagues (19) . The myoblasts exhibited >95% positive staining for the neural cell adhesion molecule (NCAM), and no contaminating immune cells or endothelial cells could be detected by flow cytometry. Myoblasts from three different donors were used in this study with similar results. Results of one donor are shown.
Monocytes and DC were used as positive or negative controls for TLR expression. Peripheral blood mononuclear cells were isolated by density gradient centrifugation using lymphocyte separating solution (PAA Laboratories) from healthy volunteers. Monocytes were enriched by 1 h adherence to plastic flasks. To generate DC, the monocytes were cultured in RPMI 1640, supplemented with GM-CSF (100 ng/ml, Novartis, Basel, Switzerland) and IL-4 (40 ng/ml, PeproTech EC, London, UK). After 6 days, the cells exhibited an immature DC phenotype (CD14 -CD1a + MHC class II low CD86 low CD80 low/-). Maturation was induced by incubation of immature DC with 5 µg/ml LPS (S. thyphi Sigma L-7261; Sigma, St. Louis, MO) for 48 h. High levels of surface MHC class II and costimulatory molecules (CD86, CD80) identified mature DC.
Monocyte-depleted peripheral blood leukocytes were cultured on irradiated RPMI 8866 feeder cells to obtain polyclonal NK cell populations for cytotoxicity assays (20). Typically, NK cell purity of the resulting cultures was 80-90%, as assessed by flow cytometric staining for CD3 -
CD56
+ cells.
For expression analysis, TE671 or myoblasts were cultured in the presence of 500 U/ml IFN-γ, 1000 U/ml TNF-α (both from Peprotech EC), different concentrations of the synthetic analog of dsRNA Poly (I:C) (Amersham Pharmacia Biotech, Freiburg, Germany) or 5 µg/ml LPS (Sigma) for 48 h. In the experiments assessing the functional consequences of TLR3 ligation, muscle cells were cultured in the absence or presence of 1000 U/ml IFN-γ for 72 h in order to upregulate TLR3 and further stimulated with Poly (I:C) at various concentrations for 24 or 48 h.
RNA extraction, cDNA synthesis, and QRT-PCR
For the QRT-PCR of myoblast cells, RNA extraction and cDNA synthesis were performed by standard methods. cDNA amplification was monitored using SYBR Green chemistry on the ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Weiterstadt, Germany) (3). Thermal cycler parameters were 2 min at 50°C, 10 min at 95°C, and 40 cycles of denaturation at
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Data were analyzed with the ABI PRISM Detection System and quantified by using the ΔC T method for relative quantification. Briefly, threshold cycles (C T ) for 18S rRNA or GAPDH (reference) and TLR or NKG2D ligands (sample) were determined in duplicate. We arbitrarily defined a calibrator value (100%) and determined the relative change (rI) in copy numbers according to the formula rI = 2 -[(C T Sample -C T Reference) -(C T Calibrator Sample -C T Calibrator Reference)]. The amplification of the specific products was controlled by dissociation curve analysis and 2% agarose gels showing a band at the expected size.
For the quantitative real-time PCR of muscle biopsy specimens, total RNA was extracted using muscle biopsy samples from 6 HIV patients with IBM/PM, 7 IBM patients, 5 nonmyopathic and 4 nonmyopathic HIV controls using the SV Total RNA kit (Promega, Madison, WI) and reverse transcribed with Superscript II Reverse Transcriptase (Invitrogen, Carlsbad, CA) following the suppliers' instructions. For amplification, we used cDNA equivalent to 1 ng RNA in a 20-µl reaction with 10 µl qPCR Mastermix Plus from Eurogentec (Philadelphia, PA), 1 µl FAMlabeled GAPDH (glyceraldehyde-3-phosphate dehydrogenase) or FAM-labeled TLR3 primer/probe mix (5′-AGTCATCCAACAGAATCATGAGACA-3′ (Assay-on-Demand, Applied Biosystems)) and 8.5 µl of molecular graded water, and amplified in a Opticon 2 cycler (MJ Research, Waltham, MA). The cycle protocol consisted of 2 min at 50°C, 10 min at 95°C, and 40 cycles of denaturation at 95°C for 15 s followed by annealing and extension at 60°C for 1 min for GAPDH and TLR3. All experiments were repeated at least once, and in the case of the outlier, twice. Data were analyzed and quantified by using the ΔC T method for relative quantification. Briefly, threshold cycles (C T ) for GAPDH (reference) and TLR3 (sample) were determined in duplicate, and relative expression (rE) in GAPDH and TLR3 for each sample was determined by the change in copy numbers, according to the formula rE = 2
-[(C GAPDH -C 
Monoclonal antibodies and flow cytometry
The following mAbs were used for the assessment of cell surface expression or for the blocking of TLR3, NKG2D, NKG2DL, HLA-DR, CD1a, CD3, CD14, CD56 (NCAM), CD80, CD86: TLR3.7 anti-TLR3-PE (eBioscience, San Diego, CA), MAB139 anti-NKG2D (R&D, Wiesbaden, Germany), AMO1 anti-MICA, BAMO1 anti-MICA/B, BAMO3 anti-MICA/B, BMO2 anti-MICB, AUMO1 anti-ULBP1, BUMO1 anti-ULBP2 (21), CUMO3 anti-ULBP3 (newly generated), L243 anti-HLA-DR-PE, HI149 anti-CD1a-PE, M5E2 anti-CD14-FITC, B159 anti-CD56-PE, L307.4 anti-CD80-PE and B-T7 anti-CD86-FITC (all BD PharMingen, Heidelberg, Germany), MEM-57 anti-CD3, and MEM-157 anti-CD56 (both from Immunotools, Friesoythe, Germany). Secondary Abs and isotype controls were mouse IgG 1 κ-PE (eBioscience), MOPC-21 mouse IgG 1 κ-FITC (Sigma) and FITC-conjugated goat anti-mouse IgG (Caltag, Hamburg, Germany).
For flow cytometry analysis, adherent cells were detached using Accutase (PAA). Subsequently, cells were incubated with the specific mAb or matched mouse Ig isotype in FACS buffer (Dulbecco´s PBS containing 0.1% BSA and 0.1% sodium azide) for 30 min on ice. For intracellular staining, cells were pretreated with permeabilizing solution (Cytofix/Cytoperm; BD PharMingen) for 20 min at 4°C, washed once with PermWash and then incubated with mAb for 30 min at 4°C. Human immunglobulines (Flebogamma; Grifols Biologicals, Los Angeles, CA) were used to prevent nonspecific binding. All specific antibodies were titrated for optimal concentrations. Specific fluorescence was measured in a Becton Dickinson FACScalibur (Becton Dickinson BD, Heidelberg, Germany) and analyzed using CellQuest software. Specific fluorescence indexes (SFI) were calculated by dividing mean fluorescence obtained with specific antibody by mean fluorescence obtained with control antibody.
Immunoblot analysis
Cells were lysed in lysis buffer (PBS containing 1% NP-40, 100 µM phenylmethylsulfonyl fluoride, aprotinin, leupeptin, pepstatin, 2 µg/ml each; all Roche Diagnostics, Mannheim, Germany). Lysates were cleared by centrifugation, and total protein concentration was determined by Bradford assay (Bio-Rad, Hercules, CA). 40 µg (DC) or 400 µg (myoblasts) of total cellular protein were size-separated on a 7.5% SDS-PAGE gel and blotted onto PVDF membranes (Amersham). Blots were blocked and incubated with 2 µg/ml anti-TLR3 mAb (TLR3.7) overnight at 4°C. Immunodetection was performed using HRP-conjugated goat antimouse Ab and ECL (both Amersham).
Reporter gene assay
TE671 or myoblasts (6×10 3 per well) were transiently transfected in 96-well plates with firefly luciferase-linked NF-κB reporter plasmids (NF-κB-Luc; 0.08 µg; Stratagene, San Diego, CA) and renilla luciferase-linked control plasmids (pRL-CMV; 0.02 µg; Promega) using FuGENE 6 Transfection Reagent (Roche Diagnostics). Cells were stimulated with different concentrations of Poly (I:C) and anti-TLR3 mAb (TLR3.7; 10 µg/ml) or isotype control Ab (10 µg/ml) for 24 h, lysed, and assayed for both firefly and renilla luciferase activities. Results were normalized to renilla activities (internal control). TNF-α-treated (5 ng/ml) myoblasts and cells cotransfected with a MEK kinase expression vector (pFC-MEKK; Stratagene) were used as positive controls (data not shown). Each experiment was performed in triplicate.
Cytokine release analysis
Release of cytokines in response to TLR3 ligation into the culture supernatants was detected by the Human Inflammation Antibody Array I (RayBiotech, Norcross, GA), following the user manual. In brief, array membranes loaded with the capture Abs were blocked and incubated with 1 ml of supernatant samples at RT for 2 h. After washing, a mixture of biotin-conjugated detection Abs was added (RT, 1−2 h). Detection was performed with HRP-conjugated streptavidin and detection buffer. Membranes were exposed to X-ray films. The 20 cytokines tested in duplicate on the used array membranes were Eotaxin, Eotanin-2, GCSF, GM-CSF, IFN-γ, IL-1α, IL1-β, IL-2, IL-3, IL-4, IL-6, IL-7, IL-8, IL-10, IL-11, IL-12p40, IL-20p70, IL-13, I-309, TIMP-2. The levels of IL-8 in culture supernatants were further measured by ELISA (BD PharMingen). It is worthy of note that anti-human IL-8 ELISA antibodies did not cross-react with bovine IL-8, possibly contained in the fetal calf serum (data not shown).
Cytotoxicity assay
Cytotoxicity was assessed in 4 h FATAL assays (22) in the absence or presence of anti-NKG2D or isotype control antibody (10 µg/ml). 24 h before the experiment, 10 6 Poly (I:C)-stimulated or untreated TE-671 cells were loaded for 5 min with 5 µl of PKH-26/Vibrant Dil solution (Cambrex, Verviers, Belgium) in serum-free medium, washed twice, and resuspended in PBS, before 2.5 µM CFSE (Invitrogen, Karlsruhe, Germany) was added for 3 min. All incubation steps were carried out at 37°C and terminated by addition of an equal volume of FCS. The cells were washed twice again and seeded into a 24-well plate at 10 5 cells/well. Conditioned media containing the appropriate stimuli were added, and the cells were allowed to equilibrate overnight. NK cells were pretreated with normal human IgG to prevent antibody-dependent cellular cytotoxicity before they were coincubated for 4 h with the fluorescence-labeled target cells at various effector:target (E:T) ratios. Cells were detached and target cell lysis was determined by flow cytometric gating on PKH-26-positive cells; then, the percentage of CFSE dim cells within this population was determined. Because PKH-26 is a membrane dye, the resulting red fluorescence is retained, whereas the cytosolic dye CFSE leaks out of lysed cells. Spontaneous leakage of CFSE was determined by incubating the target cells with medium alone.
Immunohistochemistry
For immunohistochemical analysis of human muscle cryosections, 8-to 14-µm-thick frozen sections from muscle biopsy specimens of five patients with IBM and five nonmyopathic donors were stained with anti-TLR3 (TLR3.7) followed by biotinylated horse anti-mouse secondary antibody. Cut sections were boiled in EDTA buffer (pH 9.0) for 20 min before incubation with the primary antibody to enhance intracellular epitopes. Peroxidase-labeled avidin was used to localize the secondary antibody with oxidized diaminobenzidine as chromogen. Slides were evaluated using a Zeiss AxioCam HRc microscope (Carl Zeiss Deutschland, Jena, Germany).
Statistical analysis
Where indicated, analysis of significance was performed using the one sample t test or two-tailed Student's t test with P < 0.05 considered significant and P < 0.01 considered highly significant. When the data did not fulfill the criteria of being normally distributed, nonparametric statistics (Mann-Whitney U test) were used.
RESULTS
Expression of TLR1-9 mRNA in cultured human myoblasts and TE671 cells
Myoblasts, as well as human rhabdomyosarcoma cells (TE671) were screened for mRNA expression of members of the TLR family (TLR1-9). Purified monocytes (TLR1, 2, 4-9) or LPS-matured DC (TLR3) were used as positive controls. Muscle cells constitutively expressed low levels of TLR1-7 and 9 mRNA, as shown by agarose gel electrophoresis and QRT-PCR (Fig. 1, Fig. 2A and data not shown). TLR8 mRNA was undetectable in muscle cells under any conditions.
Expression of TLR3 mRNA and protein in human myoblasts and TE671 cells: strong upregulation by Poly (I:C) and IFN-γ TLR3 mRNA was strongly up-regulated by the inflammatory cytokine IFN-γ or Poly (I:C). As shown in Fig. 1 and 2A, myoblasts constitutively expressed TLR3 mRNA. cDNA from monocytes, known to be negative for TLR3 (13, 11) were used as controls ( Fig. 2A) . Incubation with IFN-γ or the synthetic dsRNA analog Poly (I:C) induced TLR3 mRNA (mean factor of relative TLR3 gene expression: 11.2 and 7.2, respectively), in contrast to TNF-α or the TLR4 ligand LPS (1.1 and 0.5).
To corroborate our quantitative gene expression studies, we next measured the expression and regulation of TLR3 protein. In accordance with mRNA detection, human myoblasts constitutively expressed TLR3 protein, which was up-regulated upon challenge with IFN-γ and Poly (I:C) (Fig. 2B, C) . It has been reported that human fibroblasts and epithelial cells express TLR3 both on the cell surface and inside the cells, whereas monocyte-derived immature DC and CD11c+ blood DCs express TLR3 only intracellularly (10, 11) . To distinguish between extraand intracellular TLR3 protein expression, flow cytometry was performed using untreated muscle cells or muscle cells subjected to permeabilization of the cell membrane. As demonstrated in Fig. 2B , TLR3 protein could be detected mainly intracellularly. IFN-γ and Poly (I:C) up-regulated intracellular TLR3 protein, whereas extracellular levels were unaffected (Fig.  2B) . As an additional method demonstrating the expression of TLR3 protein and to prove the specificity of binding of anti-TLR3 mAb TLR3.7, we performed immunoblotting. Consistent with the flow cytometry data, IFN-γ inducible expression of TLR3 protein could be demonstrated in human myoblasts (Fig. 2C) . Monocyte-derived DCs were used as a positive control (11) .
Functional consequences of TLR 3 ligation in human muscle cells
Having demonstrated expression of TLR3 mRNA and protein in vitro, we next investigated the functional consequences of TLR3 ligation in human muscle cells.
To analyze whether dsRNA is capable of initiating the classical TLR signal transduction pathway, leading to the activation of NF-κB, we transiently transfected human muscle cells (TE671 and primary human myoblasts) with a NF-κB luciferase reporter construct. Poly (I:C) was able to activate NF-κB in TE671 and human myoblasts, demonstrating the functional signaling pathway after TLR3 ligation in muscle cells (Fig. 3A) . Cells cotransfected with a MEK kinase expression vector (pFC-MEKK) served as positive controls (data not shown). Furthermore, we included the stimulus TNF-α, known to be one of the strongest activators of NF-κB (23, 24), as a positive control. We achieved a maximum Poly (I:C) induction between 8.6 and 11.6 (depending on the donor), ~22% of the TNF-α-stimulated control myoblasts (Fig. 3A) . It has been shown that mAb TLR3.7 can suppress Poly (I:C)-mediated IFN-β production by human fibroblasts (11) and Poly (I:C)-induced TNF-α and MCP-1 secretion by human uterine epithelial cells (25). To demonstrate that Poly (I:C)-induced effects on human muscle cells areat least in part-TLR3-dependent (26), we performed assays blocking TLR3 with TLR3.7 mAb in comparison to an isotype control Ab. Importantly, incubation of human muscle cells with mAb TLR3.7 led to a considerably reduced NF-κB activation by Poly (I:C) (to 10-42%) (Fig.  3A) .
The NF-κB pathway is a critical regulator of many genes associated with inflammation. Therefore, we next examined the production of inflammatory proteins by human muscle cells and the influence of TLR3 ligation (e.g., stimulation with Poly (I:C)). For this purpose, we first used a human inflammation antibody array. Primary human myoblasts constitutively release the chemokine IL-8 and tissue inhibitor of metalloproteinase-2 (TIMP-2) into the culture supernatants (Fig. 3B) , both up-regulated by the stimulation of TLR3 via Poly (I:C). Similar results were obtained for the muscle cell line TE671 (data not shown). Subsequently, the influence of TLR3 ligation on the expression of IL-8 was investigated in more detail using an IL-8 ELISA. We found that incubation with Poly (I:C) increased IL-8 protein in the supernatant of cultured primary human myoblasts, as well as of TE671 cells. This effect was most impressive when muscle cells were pretreated with IFN-γ (Fig. 3C) . In contrast, the addition of IFN-γ alone did not induce IL-8 release (Fig. 3C ).
According to present concepts, innate immunity is regulated by signals such as NKG2D ligands that determine cellular danger levels associated with infection or other types of cellular distress. Therefore, we next investigated whether pathogenic stimulation of muscle cells would alter the expression of NKG2D ligands. Treatment of IFN-γ-prestimulated primary myoblasts with Poly (I:C) resulted in a significant up-regulation of the NKG2D ligands MHC class I-chain-related molecule A (MICA), MICB, and the UL16 binding proteins (ULBP) 2 and 3 mRNA as determined by QRT-PCR (Fig. 3D ) and protein (data not shown). Of note, treatment of muscle cells with IFN-γ alone did not induce transcription of any NKG2D ligand (data not shown). NKG2D, the receptor for NKG2D ligands, is found on cytotoxic cells. To demonstrate, in principle, that stimulation of muscle cells by a TLR3 agonist can increase their vulnerability to cell-mediated lysis, we performed in vitro lysis assays with TE671 targets and NK effector cells from polyclonal cultures (Fig. 4) . Poly (I:C) pretreated TE671 were lysed better than untreated targets (relative change between 26% and 86% depending on the effector:target ratio). Adding blocking anti-NKG2D mAb reduced the destruction of stimulated and untreated control TE671. Especially at high-effector:target ratios, the inhibitory effect seemed to be stronger on dsRNAincubated muscle cells.
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Taken together our findings indicate that muscle cells can be stimulated by dsRNA via TLR3 to activate NF-κB, produce IL-8, and express NKG2D ligands in a time-and dose-dependent manner. In addition, treatment with dsRNA renders muscle cells more susceptible to NK cell cytotoxicity.
TLR3 expression in muscle biopsy specimens of HIV/IBM, IBM, and controls
To validate our data achieved with muscle cells in vitro, we analyzed muscle biopsy specimens of six HIV patients with IBM/PM (HIV/IBM/PM), seven patients with sporadic IBM (IBM) and five nonmyopathic controls (control) and four nonmyopathic controls from HIV patients (HIV) for TLR3 mRNA expression by QRT-PCR (Fig. 5A) . TLR3 mRNA was clearly detectable in muscle biopsy specimens of inflammatory myopathies (HIV/IBM/PM and IBM). Importantly, levels of TLR3 mRNA were elevated in biopsy specimens from patients with IBM and HIV myopathies in comparison to the control specimens (Fig. 5A) . We found highly significant differences between IBM vs. control and HIV/IBM/PM vs. control samples (P<0.01; MannWhitney U Test). In the HIV/IBM/PM group, one patient exhibited extraordinarily high TLR3 mRNA values (>3 SD from group mean) and, therefore, was excluded from the statistical analysis. It is important to note that this patient had received therapy with IFN-α, a known inducer of TLR3 (reviewed by Liu and colleagues (24)), before biopsy. This might explain the drastic elevation of TLR3 levels in this patient (data not shown).
Furthermore, we performed immunohistochemistry for TLR3 in specimens with IBM (n=5) and controls (n=5). TLR3 was not detected on muscle biopsy specimens from nonmyopathic controls or noninflammatory myopathies (n=5). In contrast, TLR3 expression was detectable in sporadic IBM (IBM: 4 of 5) (Fig. 5B) . Muscle-related expression of TLR3 was mainly observed in the cytoplasm of muscle fibers and to some extent on the cell surface. Distribution was patchy, and anti-TLR3 mAb did not react on every muscle fiber within the specimen (Fig. 5B) . It is worthy to note that TLR3 was mainly localized in areas where inflammatory cells were in close contact to damaged or non-necrotic muscle fibers. Expectedly, mononuclear cells within the inflammatory tissue sections reflecting B cells, monocytes, or T-cells stained negative for TLR3 (Fig. 5B ).
Taken together, these results demonstrate expression of TLR3 in human muscle in vivo and elevated TLR3 levels in muscle biopsy specimens from patients with HIV/IBM or inflammatory myopathies.
DISCUSSION
As the largest cellular compartment of the body, skeletal muscle can be the site of many desirable and undesirable immune reactions. Our understanding of the immunoregulatory properties of this special immunological microenvironment and the ways in which immune cells interact with skeletal muscle cells under physiological and pathological conditions has considerably grown over the last years. Because muscle is one of the few body compartments that lack MHC expression under physiological conditions, immune reactions triggered by or directed against muscle cells proceed along specific pathways (1, 27, 28). The present study was aimed at elucidating the role of TLR, essential components of the innate arm of immune responses in skeletal muscle. This has implications for a better understanding of muscular
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responses to infectious or inflammatory stimuli as they occur in immune-mediated disorders of the skeletal muscle (e.g., the myositis syndromes) or during vaccinations.
TLR3 mRNA and protein were expressed in primary human skeletal muscle cells and TE671 human rhabdomyosarcoma cells (Fig. 1, 2) . Poly (I:C), a synthetic analog of dsRNA, as well as the inflammatory cytokine IFN-γ, but not LPS or TNF-α up-regulated TLR3. As functional consequences, Poly (I:C)-mediated TLR3 ligation resulted 1) in the activation of NF-κB (Fig.  3A) , 2) increased levels of IL-8 in the culture supernatants of muscle cells (Fig. 3B and C), 3) upregulation of NKG2D ligands, and lysis by NK cells (Fig. 3D, 4) . Finally, TLR3 mRNA and protein were strongly up-regulated in infectious myopathies (HIV/IBM) and idiopathic inflammatory myopathies (IBM). This corroborates our in vitro observations and provides evidence for an important role of muscle-expressed TLR3 in mediating immune responses to invading viruses, viral products, or potential endogenous danger signals (Fig. 5 ).
TLR3 protein in muscle cells was located primarily intracellularly (Fig. 2) . This finding is consistent with previous studies that suggest that the expression and localization of TLR3 protein are tightly regulated in a cell-type specific manner. In human fibroblasts, TLR3 is localized, both on the cell surface and inside the cells, whereas monocyte-derived immature DCs express TLR3 intracellularly, determined by a cytoplasmic "linker region" in TLR3 (10, 11, 29) . Although it is accepted that certain microbial components are able to interact to their respective TLR intracellularly, the precise mechanism of how they engage their intracellular TLR remains unknown to date. Along with this notion, it remains to be determined whether TLR3 shuttles between the cellular surface and intracellular compartments and where exactly TLR3 accumulates intracellularly. Funami et al. proposed that TLR3 selectively localizes to yet unidentified intracellular vesicles and that TLR3 signaling occurs intracellularly in conjunction with endosomal maturation (29). Schaefer et al. suggested that stimulation of cell surface and intracellular TLR3 could be linked to distinct signaling pathways (25). This might explain why in our study the incubation of human muscle cells with TLR3.7, although expressing only low amounts of extracellular TLR3, led to a considerably reduced NF-κB activation by Poly (I:C) (to 10-42%).
TLR3 was present in human muscle cells in vitro already under basal conditions. Its expression was enhanced not only by the dsRNA analog Poly (I:C) but also by proinflammatory stimuli such as IFN-γ (Fig. 1, 2 ). This could be necessary for rapid responses to an acute challenge with dsRNA or point to a more homeostatic function of TLR3 in cell turnover and release of mRNA. The sentinel concept of a prominent constitutive expression of TLR at sites normally devoid of pathogens-where only in the setting of infections, receptors will be challenged-has been proposed for other TLR-like TLR5 on endothelial cells of microvessels in the subepithelial compartment of the intestine (30) .
How do the functional consequences of TLR3 ligation relate to the immunobiology of muscle? The NF-κB pathway plays a crucial role in TLR signaling (31) , eventually leading to the production of inflammatory cytokines (32) . TLR3 ligation enhances NF-κB in human muscle cells, thus providing evidence of the functional relevance of TLR expression (Fig. 3A) .
It is worth noting that using an array to screen for the presence and regulation of different inflammatory cytokines by muscle cells, we found that IL-8, already present in culture supernatants of muscle cells under basal conditions, is up-regulated by TLR3 ligation (Fig. 3B  and C) . IL-8 belongs to the CXC chemokine subfamily. The repertoire of chemokines and their respective receptors expressed by leukocytic cells determines their ability to respond to specific stimuli and directs their migration to sites of inflammation. In general, chemokines and their receptors are induced in different types of tissue cells and infiltrating leukocytes by inflammatory cytokines, microbial toxins, and other conditions that disturb homeostasis (for a review, see Ref. 32) . The factors responsible for migration of immune cells into the muscle are unclear. Adhesion molecules, such as VCAM-1 and ICAM, and metalloproteinases (MMP) have been reported to be up-regulated on the endothelial cell wall, as well as on the T cells and the invaded areas of the muscle fibers (33) (34) (35) (36) . Cytokines responsible for T cell activation and upregulation of the adhesion molecule have also been found, but their presence in the muscle tissue of IBM patients has been inconsistent (37) (38) (39) . Apart from the role of cytokines, the trafficking of lymphocytes into the sites of inflammation is controlled by chemokines (40) (41) (42) . The expression of chemokines and their ligands in myopathies is an area of intense research (43) (44) (45) . Consistent with our data, a recent study has shown that CD40 ligation increases IL-8 production by myoblasts, demonstrating that myoblasts are able to secrete this cytokine (46) . Thus, our data suggest that dsRNA generated by viruses up-regulates inflammatory cytokines like IL-8 ( Fig. 3B and C) and attracts leukocytes to the site of inflammation via TLR3.
We could also show that myoblasts stimulated with Poly (I:C) express ligands for the NKG2D receptor, which is found on NK cells, activated CD8 T cells, and macrophages (Fig. 3D) . According to present concepts, innate immunity is regulated by receptors that capture danger signals associated with infection or cellular distress. NKG2D is one of the best characterized receptors that is associated with responses to cellular distress-like transformation, infection, or cell stress (for a review, see Ref. 47 ). Up-regulation of its ligands-in humans, these are MICA, MICB (48) , and ULBP1, 2, 3, and 4 (49, 50)-could be one mechanism by which infected muscle cells communicate directly to cells that can kill them and clear up. This hypothesis is also supported by our finding that Poly (I:C) stimulation of muscle cells increases their susceptibility to NK cell-mediated lysis (Fig. 4) . Furthermore, NKG2D ligand/receptor interactions might be a novel effector pathway in the idiopathic inflammatory myopathies. Sporadic IBM is characterized by primary endomysial inflammation and invasion of sensitized CD8 cells to MHC class I-expressing nonnecrotic muscle fibers (51) (52) (53) . By acting as nonprofessional antigenpresenting cells (2, 3, 54) , muscle fibers present their antigen to CD8, as well as CD4 T cells. NKG2D is a costimulatory molecule of CD8 T cells in humans and mice (55, 56, 47) , thus qualifying NKG2D ligand/receptor interactions to enhance muscle destruction in this disease entity (H. Wiendl et al., unpublished observations).
Our data demonstrating strong TLR3 up-regulation in IBM and HIV/IBM (Fig. 5) supports the idea of an important role of muscle-expressed TLR3. Although conflicting results (or even negative reports) exist concerning the direct infection of muscle cells by viruses, it is tempting to speculate that TLR3 could act as a direct link between the viral components and the respective immune response. Not mutually exclusive, TLR3 could be up-regulated in the presence of endogenous danger or stress signals and contribute to the inflammatory cascade in sporadic IBM (55, 56) . Our findings showing that TLR3 is up-regulated by proinflammatory stimuli (IFN-γ) alone (Fig. 1, 2) and that the prestimulation of muscle cells with IFN-γ sensitizes for the subsequent stimulation with Poly (I:C) support this hypothesis (Fig. 3, 5) . Thus, TLR3 could act as a sensor molecule linking signals of an inflammatory milieu with the subsequent recruitment of inflammatory cells and the clearance or damage of target tissues. This also relates to a concept of "sterile inflammation," driven by ligands from damaged cells/endogenous components that are released from host cells during processes such as necrosis, apoptosis, and inflammation (57, 58) .
Our observed TLR expression in muscle has broad implications as it could play an important role in many different immune reactions that occur in this tissue. Not only could TLR3 play a role in linking a primary (viral or endogenous) stimulus with a subsequent cellular recruitment and injury in autoimmune muscle disorders such as sporadic IBM or in various muscle infections. Further, TLR3 could modulate the immune responses after protein or DNA-based vaccinations and efficiently enhance muscle-directed antigen-specific and nonantigen-specific immune responses in either condition. This should be kept in mind when considering adjuvants to modern muscle-related vaccination strategies. Moreover, the innate responses of muscle cells and their armamentarium of cytokines, chemokines, and MMP do not only affect the mechanisms of immune surveillance but may also be involved in the processes of muscular degeneration and regeneration cultured in the absence or in the presence of Poly (I:C) (25 µg/ml), IFN-γ (500 U/ml), TNF-α (1000 U/ml), or LPS (5 µg/ml) were harvested after 48 h of culture and analyzed for the expression of TLR3 mRNA by QRT-PCR. Bars represent the relative gene expression of TLR3 calculated in relation to unstimulated myoblasts. Monocytes were used as negative controls. TLR3 mRNA was expressed constitutively and up-regulated by its ligand Poly (I:C) and by IFN-γ, but not by the TLR4 ligand LPS or TNF-α. B) Primary human myoblasts were cultured as described under (A) and expression of TLR3 protein was assessed by flow cytometry using the specific monoclonal antibody TLR3.7 (10 µg/ml). Cell surface and intracellular staining are shown. TLR3 protein was located mainly intracellularly. Open histograms represent staining with the specific antibody underlaid with the isotype-matched control antibody (shaded histograms). Numbers in the upper corner indicate the SFI values specific for the TLR3 mAb. C) Immunoblotting of TLR3 protein in lysates of myoblasts cultured as described under (A) in the absence or presence of IFN-γ. Equal amounts of total myoblast cell protein were size-separated and subjected to immunoblotting using TLR3.7 mAb (2 µg/ml). Immature and LPS-matured DC served as positive controls. The arrowhead indicates TLR3 protein with a molecular mass (m) of ~120 kDa in myoblasts, confirming the flow cytometry results. One representative experiment of 3 is shown (A, B, C) . 3 . Stimulation of muscle cells with Poly (I:C) leads to dose-dependent activation of NF-κB, production of IL-8 and time-dependent up-regulation of NKG2D-ligand mRNA. A) Primary human myoblasts were transfected transiently with firefly luciferase-linked NF-κB reporter plasmids (NF-κB-Luc) and renilla luciferase-linked control plasmids (pRL-CMV). Cells were stimulated with different concentrations of Poly (I:C) and anti-TLR3 mAb (TLR3.7; 10 µg/ml) or isotype control Ab (10 µg/ml) where indicated, IFN-γ (1000 U/ml), or TNF-α (5 ng/ml) for 24 h. Then they were lysed and assayed for both firefly and renilla luciferase activities. Results were normalized to renilla activities (internal control). Cells cotransfected with a MEK kinase expression vector (pFC-MEKK) were used as positive controls (not shown). Each experiment was performed in triplicate. Means and standard deviations of one representative experiment are shown (n=4). Two-tailed t test against unstimulated controls (**P<0.01, *P<0.05). B) Primary human myoblasts cultured in the absence (left blot) or in the presence of Poly (I:C) (25 µg/ml; right blot) for 48 h. Secretion of different inflammatory cytokines into the culture supernatants was assayed by a human inflammation antibody array (see Material and Methods). Both IL-8 and TIMP-2, produced into the supernatant of unstimulated myoblasts, are up-regulated by Poly (I:C). Membrane-bound biotin-conjugated Ig produces positive signals (control), which are also used to identify the orientation of the membrane. Two independent experiments were performed, one representative experiment is shown. C) Primary human myoblasts and TE671 were cultured in the absence (bright bars) or in the presence of IFN-γ (1000 U/ml, solid bars) for 72 h and subsequently stimulated with different concentrations of Poly (I:C) for 48 h in serum-containing medium. Supernatants were taken and the concentration of IL-8 in the conditioned media was measured by ELISA. Data show the mean and standard deviations of one representative experiment done in duplicate (n=4). Two-tailed t test against unstimulated controls (**P<0.01, *P<0.05). D) Myoblasts were pretreated with 1000 U/ml IFN-γ as described in Figure 3C and stimulated with the synthetic analog of dsRNA (Poly (I:C) 25 µg/ml) for 24 and 48 h. Human MICA, MICB, and ULBP1, 2, 3 mRNA levels were quantified by QRT-PCR. Results were normalized to the 18S housekeeping gene. Bars represent the relative gene expression of the NKG2D-ligands calculated in relation to unstimulated myoblasts. Means and standard deviation of two representative experiments done in duplicates are shown. One-sample t test (theoretical mean = 1; **P<0.01, *P<0.05). 5 . Detection of TLR3 mRNA and protein in muscle biopsy specimens. A) Human TLR3 mRNA levels in muscle biopsy specimens of 6 HIV patients with inclusion body myositis/polymyositis (IBM/PM), 7 cases of sporadic IBM (IBM), 5 nonmyopathic controls (control) and 4 nonmyopathic controls of HIV patients (HIV) were quantified by QRT-PCR. Fold change levels of TLR3 were normalized to relative expression of the GAPDH housekeeping gene. Data show the mean fold-change of TLR3 compared with GAPDH of one experiment done in duplicates. Group mean differences were evaluated with the Mann-Whitney U Test. Significant differences were found between HIV vs. HIV/IBM and HIV vs. control samples (P<0.05), and highly significant differences between IBM vs. control and HIV/IBM vs. control samples (P<0.01). B) Detection of TLR3 (TLR3.7) was performed by immunohistochemistry. Transverse cryostat sections from a patient with IBM stained with anti-TLR3 mAb TLR3.7 and isotype control antibody. Of note, mononuclear cells such as T-cells, B-cells, and monocytes surrounding muscle fibers stain negative for TLR3. × 40 before magnification.
